Phantom Cosmological Model with Observational Constraints in f(Q)$f(Q)$ Gravity
Annalen der Physik · 2023-05 · 535 (5)
DOI: 10.1002/andp.202200626 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annalen der Physik, online erschienen am 03.04.2023. Verfasst von Shubham A. Narawade und 1 weiteren Autor:innen. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
In this paper, the cosmological model of the Universe has been presented in gravity and the parameters are constrained from the cosmological data sets. At the beginning, a well motivated form of has been employed, where α, β, and n are model parameters. The Hubble parameter is obtained in redshift with some algebraic manipulation from the considered form of . Then it is parameterized with the recent data and data using Markov chain Monte Carlo analysis. The obtained model parameter values are validated with the baryon acoustic oscillation data set. A parametrization of the cosmographic parameters shows the early deceleration and late time acceleration with the transition at . The diagnostics gives positive slope which shows that the model is in the phantom phase. Also the current age of the Universe has been obtained as, . Based on the present analysis, it indicates that the gravity may provide an alternative to dark energy for addressing the current cosmic acceleration.
Zitieren
APA
Narawade, S. A., & Mishra, B. (2023). Phantom Cosmological Model with Observational Constraints in f(Q)$f(Q)$ Gravity. Annalen der Physik, 535(5). https://doi.org/10.1002/andp.202200626
Vancouver
Narawade SA, Mishra B. Phantom Cosmological Model with Observational Constraints in f(Q)$f(Q)$ Gravity. Annalen der Physik. 2023;535(5). doi:10.1002/andp.202200626
BibTeX
@article{Narawade2023,
author = {Narawade, Shubham A. and Mishra, Bivudutta},
title = {Phantom Cosmological Model with Observational Constraints in f(Q)$f(Q)$ Gravity},
journal = {Annalen der Physik},
year = {2023},
volume = {535},
number = {5},
doi = {10.1002/andp.202200626}
}
EUVIMED